Europe and North America Digital Therapeutic (DTx) Market - Industry Trends and Forecast to 2030

Europe and North America Digital Therapeutic (DTx) Market - Industry Trends and Forecast to 2030

Europe and North America Digital Therapeutic (DTx) Market, By Product Type (Hardware Product, Solutions/Software, Service), Application (Treatment/ Care-Related Applications, Preventive Applications), Purchase Mode (Group Purchase Organization, Individual), Sales Channel (B2B, B2C), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe)– Industry Trends & Forecast to 2030.

Market Definition

Digital therapeutics (DTx) deliver therapeutic interventions directly to patients using employing evidence-based, remote assessed software to serve, manage, and avert a broad spectrum of behavioral, mental, and physical disorders. They are utilized alone or mixed with medications, devices, or other therapies to optimize patient care and health outcomes. Rising remote access to therapies clinically tested as safe and effective is one of the properties of digital therapeutics (DTx) during the treatment. It provides easy treatment as per the patient’s schedule and in the privacy and safety of their home environment. They are easily available and often accessible through patient-owned devices (smartphones, tablets). The rise in demand for digital therapeutics is increasing worldwide due to the prevalence of chronic diseases such as diabetes, and hypertension, among others, hence expected to drive market growth. Moreover, technological advancements have also provided the market with elevated growth.

Digital therapeutics (DTx) delivers evidence-based therapeutics to patients that are operated by high-quality software programs to forbid, cope, or nurse a medical disorder or disease. They are utilized individually or in recitals with medicaments, devices, or other remedies to revamp patient care and health upshot. DTx products subsume advanced technology best applications relating to design, clinical affirmations, usability, and data safety. They are corroborated by legislative bodies as required to hold up product asserts regarding peril, potency, and deliberated ply. DTx licenses patients, healthcare providers and payers with attainable tools for inscribing various conditions through high standard, sheltered and virtually data–driven medications.

Some of the market players provide products and services for chronic disorders, which are mainly used for the old age population. During the last few years, new innovative software has been coming up to let people get more attached to digital therapeutics for ease. A large number of market players are involved in providing services to uphold digital therapeutics, which paves the way for market growth.

Accounting for the diversity of products across the DTx industry, individual digital therapeutics have the potential to provide patients, clinicians, and payers with novel therapy options for unmet medical needs, be used independently or in conjunction with other therapies, enhance, support, or optimize current medical treatments, integrate into medical guidelines and best practices and enable the expansion of care outside of a traditional clinic setting.

Market Segmentation

Europe and North America digital therapeutic (DTx) market is categorized into five segments which are based on product and service type, application, purchase mode and sales channel and geography.
• On the basis of product and service type, Europe and North America digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service
• On the basis of application, Europe and North America digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications
• On the basis of purchase mode, the Europe and North America digital therapeutic (DTx) market is segmented into group purchase organizations and individual
• On the basis of sales channel, Europe and North America digital therapeutic (DTx) market is segmented into B2B and B2C
• On the basis of geography, the Europe and North America digital therapeutic (DTx) market is segmented into U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe

Market Players

Some of the key market players operating in the Europe and North America digital therapeutic (DTx) market are listed below:
• Noom
• Atentiv
• Cognoa
• Kaia Health
• Ginger
• Livongo Health
• Mango Health
• Natural Cycles
• Cognifit
• Fitbit, Inc.
• Omada Health
• Propeller Health
• Welldoc, Inc.
• Smart Patient GMBH
• Mindstrong Health
• Ayogo Health
• Better Therapeutics
• 2morrow
• Canary Health
• Click Therapeutics
• Pear Therapeutics
• Voluntis
• Akili Interactive Labs
• Samsung
• Resmed
• GAIA AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.